Jove
Visualize
Contact Us

Related Concept Videos

Pleural Effusion I: Introduction01:25

Pleural Effusion I: Introduction

4.0K
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
4.0K
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

664
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
664
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
  1. Home
  2. A Rare Diagnosis Of Primary Effusion Lymphoma Presenting With Three-cavity Effusion: A Case Report.
  1. Home
  2. A Rare Diagnosis Of Primary Effusion Lymphoma Presenting With Three-cavity Effusion: A Case Report.

Related Experiment Video

Surgical Treatment of an Endolymphatic Sac Tumor
04:34

Surgical Treatment of an Endolymphatic Sac Tumor

Published on: May 26, 2023

1.5K

A Rare Diagnosis of Primary Effusion Lymphoma Presenting With Three-Cavity Effusion: A Case Report.

Hari Movva1, Yasamin Rastgar2, Kinan Obeidat1

  • 1Internal Medicine, University of Texas Medical Branch at Galveston, Galveston, USA.

Cureus
|September 8, 2025

View abstract on PubMed

Summary
This summary is machine-generated.

A case report details a transgender woman with advanced HIV/AIDS and non-adherence to ART who developed primary effusion lymphoma (PEL). This rare cancer presented as multi-cavity effusions and spontaneous bacterial peritonitis.

Keywords:
anti-retroviral therapyeffusionhiv aidsimmunocompromised patientprimary effusion lymphomathree-cavity effusion

More Related Videos

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

11.6K
Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting
07:36

Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting

Published on: May 1, 2015

14.9K

Related Experiment Videos

Surgical Treatment of an Endolymphatic Sac Tumor
04:34

Surgical Treatment of an Endolymphatic Sac Tumor

Published on: May 26, 2023

1.5K
Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

11.6K
Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting
07:36

Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting

Published on: May 1, 2015

14.9K

Area of Science:

  • Oncology
  • Infectious Diseases
  • Hematology

Background:

  • Primary effusion lymphoma (PEL) is an aggressive non-Hodgkin lymphoma associated with human immunodeficiency virus (HIV).
  • PEL typically presents as serous effusions without a discernible solid tumor mass.
  • Management challenges include patient non-adherence to antiretroviral therapy (ART) and the rarity of PEL.